Gland Pharma IPO


Staff member
Gland Pharma IPO

Opened today - 9th November.
Closes - 11th November.

It's an excellent business, but the IPO is pricey.

Listing gains are unlikely as the IPO is fully priced and also because of the size of the IPO.

Gland Pharma can be a good long term investment but the key risk is that the company is owned by a Chinese promoter.

Till now the company is not present in China, but it intends to increase its business in China. Also, the company is dependent on China for many key raw materials.

If for some reason trade relations between India and China deteriorate, the company's business can be adversely affected.